(S)-(+)-1-甲基-3-苯基丙胺 | 4187-57-9

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: (S)-(+)-1-甲基-3-苯基丙胺
• 中文别名: (S)-(+)-1-甲基-3-苯丙胺
• 英文名称: (S)-1-methyl-3-phenylpropylamine
• 英文别名: (S)-4-phenylbutan-2-amine；(S)-2-amino-4-phenylbutane；(S)-4-phenyl-2-butylamine；4-phenylbutan-2-amine；(S)-α-methylbenzenepropanamine；(S)-4-phenyl-2-butanamine；(2S)-4-phenylbutan-2-amine
• CAS: 4187-57-9
• 化学式: C₁₀H₁₅N
• mdl: MFCD00008090
• 分子量: 149.236
• InChiKey: WECUIGDEWBNQJJ-VIFPVBQESA-N

物化性质

• 熔点：
  143°C (estimate)
• 沸点：
  230.33°C (estimate)
• 密度：
  0.9285 (estimate)
• 稳定性/保质期：
  避免与不相容的材料接触。

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2921499090
• 储存条件：
  密封储存，应存放在阴凉、干燥的库房中。

SDS

Name:	(S)-(+)-1-Methyl-3-Phenylpropylamine Material Safety Data Sheet
Synonym:	(S)-2-Amino-4-Phenylbutan
CAS:	4187-57-9

Section 1 - Chemical Product MSDS Name:(S)-(+)-1-Methyl-3-Phenylpropylamine Material Safety Data Sheet
Synonym:(S)-2-Amino-4-Phenylbutan

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
4187-57-9	(S)-(+)-1-Methyl-3-Phenylpropylamine	ca. 100	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 4187-57-9: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H15N
Molecular Weight: 149.1117

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents, strong acids.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 4187-57-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(S)-(+)-1-Methyl-3-Phenylpropylamine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 4187-57-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 4187-57-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 4187-57-9 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (S)-(+)-1-甲基-3-苯基丙胺 在 氢气 、 镍 作用下， 以 甲苯 为溶剂， 70.0 ℃ 、10.0 kPa 条件下， 反应 48.0h， 生成 1-甲基-3-苯基丙胺
  参考文献：
  名称：

  异种阮内镍和钴催化剂用于胺的消旋化和动力学动力学拆分

  摘要：

  研究阮内金属作为手性胺的外消旋和动态动力学拆分（DKR）的非均相催化剂，可以替代钯或钌等金属。雷尼镍和钴都能够以高选择性选择性消旋各种手性胺。在苄基伯胺的外消旋化中，副产物（例如仲胺）的少量形成可以通过改变氢压得到抑制。在阮内催化剂上脂肪胺的外消旋中，选择性很高，对映体胺是唯一的产物。外消旋脂肪胺的DKR可以在一个锅中用固定的南极假丝酵母脂肪酶B和阮内镍进行。对于2-己胺，获得95％的乙酰化酰胺产率，而ee为97％。在DKR期间，注意力集中在酶和金属催化剂的相容性上。对于苄基伯胺，提出了一种两锅法，其中液体在包含固体外消旋催化剂和生物催化剂的两个容器之间交替穿梭。在4个这样的循环后，以94％的收率和大于90％的ee获得（R）-1-苯基乙胺的酰胺。

  DOI：

  10.1002/adsc.200700336
• 作为产物：
  描述：

  1-甲基-3-苯基丙胺 在 钯 sodium azide 、 氢气 、 三乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 13.25h， 生成 (S)-(+)-1-甲基-3-苯基丙胺
  参考文献：
  名称：

  胺通过手性2,4,6-三苯基吡啶鎓中间体的立体选择性转化

  摘要：

  我们在此报告了手性2,4,6-三苯基吡啶鎓四氟硼酸酯2a和2b的制备和亲核取代。三苯基吡啶中间体是由高手性胺（1a，1b）和2,4,6-三苯基吡啶四氟硼酸酯生成的，并用作立体选择性亲核取代的底物。已经研究了取代反应中的转化度。获得的醇（3a，3b）和叠氮化物（4a，4b）产物的构型转化率分别大于99％和96–98％。

  DOI：

  10.1016/s0957-4166(01)00343-3

文献信息

• One-Pot Transformation of Ketoximes into Optically Active Alcohols and Amines by Sequential Action of Laccases and Ketoreductases or ω-Transaminases
  作者：Raquel S. Correia Cordeiro、Nicolás Ríos-Lombardía、Francisco Morís、Robert Kourist、Javier González-Sabín

  DOI：10.1002/cctc.201801900

  日期：2019.2.20

  An enzymatic one‐pot process for asymmetric transformation of prochiral ketoximes into alcohols or amines was developed by sequential coupling of a laccase‐catalyzed deoximation either with a ketone reduction (ketoreductase, KRED) or bioamination (ω‐transaminase, ω‐TA) in aqueous medium. An accurate selection of biocatalysts provided the corresponding products in excellent enantiomeric excesses and

  通过将漆酶催化的脱肟与酮还原（酮还原酶，KRED）或生物胺化（ω-转氨酶，ω-TA）相继偶联，开发了一种酶法一锅法，用于将前手性酮肟不对称转化为醇或胺。中等的。正确选择生物催化剂后，相应的产品的对映体过量非常好，醇的总转化率从83％到> 99％，胺的总转化率从70％到> 99％。同样，仅使用1％（w / w）的Cremophor®（一种聚乙氧基化蓖麻油）作为助溶剂，可使手性醇级联反应中的浓度达到100 mM。
• A Single Lipase-Catalysed One-Pot Protocol Combining Aminolysis Resolution and Aza-Michael Addition: An Easy and Efficient Way to Synthesise β-Amino Acid Esters
  作者：Fan Xu、Qiongsi Wu、Xiaoyang Chen、Xianfu Lin、Qi Wu

  DOI：10.1002/ejoc.201500760

  日期：2015.8

  was developed to obtain chiral β-amino acid esters with lipase B from Candida antarctica (CAL-B) as the only catalyst. This method is conducted under mild reaction conditions and is very easy to handle. After a series of detailed optimization studies, ten racemic aromatic or aliphatic amines were subjected to this one-pot procedure, and twelve chiral β-amino acid esters and ten chiral amides were successfully

  开发了一种结合 aza-Michael 加成和氨解拆分的新型一锅法，以来自南极念珠菌 (CAL-B) 的脂肪酶 B 作为唯一催化剂获得手性 β-氨基酸酯。该方法在温和的反应条件下进行，非常容易操作。经过一系列详细的优化研究，10 种外消旋芳香族或脂肪族胺经过此一锅法处理，成功合成了 12 种手性 β-氨基酸酯和 10 种手性酰胺，其 ee 值在理论产率下具有优异的值。放大程序也没有明显降低反应速率或对映选择性，这使得该方法适用于手性 β-氨基酸酯的大规模生产。
• Arylethanolamines derived from salicylamide with .alpha.- and .beta.-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers and related salicylamides
  作者：James E. Clifton、Ian Collins、Peter Hallett、David Hartley、Lawrence H. C. Lunts、Philip D. Wicks

  DOI：10.1021/jm00348a013

  日期：1982.6

  A series of phenethanolamines (3) based on salicylamide has been prepared and shown to possess beta-adrenergic blocking properties. When the basic nitrogen atom was substituted by some aralkyl groups, the compounds also blocked alpha-adrenoceptors. The 1-methyl-3-phenylpropyl derivative labetalol (34) is antihypertensive in animals and man, and syntheses of its four stereoisomers are described. The

  已经制备了一系列基于水杨酰胺的苯乙醇胺（3），并显示出具有β-肾上腺素阻断特性。当碱性氮原子被某些芳烷基取代时，这些化合物也会封闭α-肾上腺素受体。1-甲基-3-苯基丙基衍生物拉贝洛尔（34）在动物和人类中均具有降压作用，并描述了其四种立体异构体的合成。在两个不对称中心具有R构型的对映体90具有大部分的β-阻断活性，但是几乎没有α-阻断活性。在醇碳上具有S构型并且在氨基取代基上具有R构型的化合物主要是α-肾上腺素受体阻断剂89。
• Connecting Unexplored Protein Crystal Structures to Enzymatic Function
  作者：Fabian Steffen-Munsberg、Clare Vickers、Ahmad Thontowi、Sebastian Schätzle、Tony Tumlirsch、Maria Svedendahl Humble、Henrik Land、Per Berglund、Uwe T. Bornscheuer、Matthias Höhne

  DOI：10.1002/cctc.201200544

  日期：2013.1

  Digging in the database: Four synthetically useful transaminases for which no function was known were studied by evaluating a set of eight amino donors and seven acceptors (see figure). The four enzymes differ substantially in their catalytic properties and substrate preferences. We also used the enzymes in the asymmetric synthesis of a range of chiral amines and observed excellent enantioselectivities

  在数据库中进行挖掘：通过评估一组八个氨基供体和七个受体，研究了四个未知功能的合成有用的转氨酶（见图）。四种酶的催化特性和底物偏好存在很大差异。我们还在一系列手性胺的不对称合成中使用了这些酶，并观察到出色的对映选择性和转化率。
• Vicinal Diamines as Smart Cosubstrates in the Transaminase-Catalyzed Asymmetric Amination of Ketones
  作者：Stefan E. Payer、Joerg H. Schrittwieser、Wolfgang Kroutil

  DOI：10.1002/ejoc.201700253

  日期：2017.5.3

  Transaminases (TAs) have recently been established as catalysts for the asymmetric, reductive amination of prochiral ketones. Depending on the ketone substrate and the amine donor (the cosubstrate), equilibrium constants may limit high conversions; thus, methods to overcome this limitation are required. Removal of the co-product from the reaction equilibrium through spontaneous, intramolecular reactions

  转氨酶 (TA) 最近已被确定为前手性酮不对称还原胺化的催化剂。根据酮底物和胺供体（共底物），平衡常数可能会限制高转化率；因此，需要克服这种限制的方法。通过自发的分子内反应从反应平衡中去除副产物为这个问题提供了成功的解决方案。因此，这些胺供体被命名为“智能共底物”。在这里，我们比较了各种双功能胺供体，包括作为潜在结构共底物基序的连二胺。在 TA 催化的 1,2-二胺脱氨基作用后，所得 α-氨基酮的自发二聚化和氧化得到杂芳族吡嗪。